MLH1-deficient tumor cells accumulate cytoplasmic DNA to activate the cGAS-STING pathway, which sensitizes MLH1-deficient tumors to immunotherapy by promoting initiation and infiltration of antitumor CD8+ T cells. Here, CGAS is linked to neoplasm.